6 stories mentioning ETONUpdated 26d ago
Every FINWIRES story that references ETON, newest first.
Paul V Maier, Director, on August 28, 2026, sold 50,000 shares in Eton Pharmaceuticals (ETON) for $2,953,572. Following the Form 4 filing with the SEC, Maier has control over a total of 59,745 common shares of the company, with 59,745 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/xslF345X05/rdgdoc.xml
David Krempa, Chief Business Officer, on August 24, 2026, sold 25,000 shares in Eton Pharmaceuticals (ETON) for $1,626,750. Following the Form 4 filing with the SEC, Krempa has control over a total of 37,025 common shares of the company, with 37,025 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1710340/000143774926028846/xslF345X05/rdgdoc.xml
Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.5%.The iShares Biotechnology ETF (IBB) lost 0.5%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth (UNH) executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. UnitedHealth shares were up 0.8%.Valneva (VALN) shares jumped 25% after the company and Pfizer (PFE) said the European Medicines Agency validated their marketing authorization application for their Lyme disease vaccine candidate, starting the regulatory review process. Pfizer shares were fractionally lower.Eton Pharmaceuticals (ETON) shares surged 41%. The company late Thursday reported Q2 adjusted earnings and revenue above market expectations and raised full-year 2026 sales guidance.Zentalis Pharmaceuticals (ZNTL) shares fell past 12% in Friday trading, a day after the company priced an offering of 23 million shares at $3.50 each, targeting about $80.5 million in gross proceeds.
Eton Pharmaceuticals (ETON) reported Q2 adjusted earnings and revenue above market expectations and raised full-year 2026 sales guidance late Thursday.Shares soared 39% amid a surge in intraday trading volume to over 1.29 million from a daily average of about 472,000.Star Equity (STRR) entered into a merger agreement to acquire Harte Hanks (HHS). The deal values Harte at $5 per share, or about $38.4 million in terms of equity value.Shares of Harte Hanks surged 51% as intraday trading volume catapulted to over 3.98 million from a daily average of roughly 6,000.International Money Express (IMXI) shares were up more than 23% after Western Union's (WU) pending acquisition of the company received approval from the New York State Department of Financial Services, with Western Union agreeing to certain commitments related to remittance services and locations.Over 3.89 million shares of International Money Express traded intraday, versus a daily average of roughly 436,000.Price: $56.95, Change: $+16.15, Percent Change: +39.57%
Jennifer Mckie Adams, Director, on June 17, 2026, sold 50,000 shares in Eton Pharmaceuticals (ETON) for $1,623,795.SEC Filing:https://www.sec.gov/Archives/edgar/data/1710340/000143774926021000/xslF345X05/rdgdoc.xml
David Krempa, Chief Business Officer, on May 22, 2026, sold 100,000 shares in Eton Pharmaceuticals (ETON) for $3,229,923. Following the Form 4 filing with the SEC, Krempa has control over a total of 25,249 common shares of the company, with 25,249 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1710340/000143774926018628/xslF345X05/rdgdoc.xml
